Back to search

Article

Exploring New Horizons: A Novel Cdk5 Inhibitor Restoring Cognitive Function and Alleviating Type 2 Diabetes

2024-10-02

Abstract excerpt

Type 2 diabetes (T2D) is a metabolic disorder frequently associated with cognitive decline, making T2D patients susceptible to dementia. Often referred to as type 3 diabetes, Alzheimer’s disease (AD) shares a close association with hyperglycemia and insulin dysregulation. Despite this, anti-diabetic medications have proven beneficial in reducing cognitive impairment induced by T2D. Previous research, including our...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16afff43-2a03-5c67-9c22-5fe18c5c68fa
DOI
10.1101/2024.09.30.615976
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring New Horizons: A Novel Cdk5 Inhibitor Restoring Cognitive Function and Alleviating Type 2 DiabetesDOI 10.1101/2024.09.30.615976
Select a neighboring publication to make it the new centre.